Health Condition 1: R739- Hyperglycemia, unspecified
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patients of either gender (male and female) Patients aged between 20 and 70 years Patients diagnosed with prediabetes based on blood investigations such as HbA1c, fasting blood glucose, or oral glucose tolerance test Patients with stress-related prediabetic condition Patients without microvascular or macrovascular complications Patients willing to participate and provide informed consent Patients available for regular follow-up during the study period
Exclusion criteria
Exclusion criteria: Patients with diagnosed diabetes mellitus with complications Patients with microvascular or macrovascular complications such as retinopathy, nephropathy, neuropathy, or cardiovascular disease Patients with severe systemic or life-threatening illnesses Patients with autoimmune disorders Pregnant or lactating women Patients with HbA1c greater than 11% Patients currently on long-term steroid or immunosuppressive therapy Patients unwilling to participate or unable to comply with follow-up Patients aged below 20 years or above 70 years
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Change in fasting blood glucose and postprandial blood glucose levels after treatmentTimepoint: Outcomes will be assessed at baseline (Day 0), at 3 months (12 weeks), 6 months (24 weeks), and 12 months (end of treatment). | — |
Secondary
| Measure | Time frame |
|---|---|
| NILTimepoint: NIL | — |
Countries
India
Contacts
Sonajirao Kshirsagar Homeopathic Medical College